Data / Form D filings / HEMOSHEAR THERAPEUTICS, INC.
HEMOSHEAR THERAPEUTICS, INC.: Form D filings
HEMOSHEAR THERAPEUTICS, INC., a biotechnology company in Charlottesville, VA, filed 2 Form D notices with the SEC between 2021 and 2023. The latest, on November 14, 2023, reports $3.5 million sold of a $8 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 501 LOCUST AVENUE, SUITE 301, Charlottesville, VA, 22902
- Phone
- (434) 872-0196
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1846099
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 14, 2023 | New notice | $8,000,000 | $3,500,000 | $4,500,000 | 4 | Oct 17, 2023 | sec.gov |
| Feb 18, 2021 | New notice | $48,102,069 | $43,102,017 | $5,000,052 | 17 | Feb 5, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael A Innes | Executive Officer | |
| David L Friedman | Director | |
| Patrick A Horn | Executive Officer | |
| Brian A Johns | Executive Officer | |
| John M Tilton | Director | |
| H. Thomas Watkins III | Director | |
| John L Brooks III | Director | |
| Kathleen M Metters | Director | |
| Aric Holsinger | Executive Officer | |
| Brian M Warmhoff | Executive Officer, Director | |
| Robert J Gould | Director |
Other biotechnology companies in Virginia that filed recently
- GENHEALTH, INC. $16.5 million · Sep 29, 2026
- SalivIQ Diagnostics Inc. $1.9 million · Sep 23, 2026
Every Form D from the week of Nov 13, 2023 · All recent filings in Virginia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what HEMOSHEAR THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.